De novo hepatic tumors following portocaval shunt for Budd-Chiari syndrome;De-novo-lebertumoren nach portokavalem shunt bei Budd-Chiari-syndrom

Chirurgische Gastroenterologie mit Interdisziplinaren Gesprachen

Volumn 14, Issue 4, 1998, Pages 318-322

  Braun, F ^a   Nolte, W ^a   Lorf, Th ^a   Canelo, R ^a   Sattler, B ^a   Muller D ^a   Vosshenrich, R ^a   Ramadori, G ^a   Ringe, B ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Atrophic hypertrophic complex; Budd Chiari syndrome; Focal nodular hyperplasia; Liver tumors; Portocaval shunt

Indexed keywords

ADULT; ARTICLE; BUDD CHIARI SYNDROME; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; LIVER TUMOR; PORTOSYSTEMIC ANASTOMOSIS; SURGICAL TECHNIQUE;

EID: 0032411448     PISSN: 01779990     EISSN: None     Source Type: Journal    
DOI: 10.1159/000012515     Document Type: Article

References (26)

1. Budd G: On Diseases of the Liver, 1st ed. London, Churchill, 1845, p 146.
2. Chiari H: Über die selbständige Phlebitis Obliterans der Hauptstämme der Venae Hepaticae als Todesursache. Beitr Pathol 1899;26:1-18.
3. Orloff MJ, Orloff MS: Budd-Chiari syndrome and veno-occlusive disease; in Blumgart LH (ed): Surgery of the Liver and Biliary Tract. Edinburgh, Churchill Livingstone, 1988, pp 1725-1760.
4. Tilanus HW; Budd-Chiari syndrome. Br J Surg 1995;82:1023-1030.
5. Blum U, Rössle M, Haag K, Ochs A, Blum HE, Hauenstein KH, Astinet F, Langer M: Budd-Chiari syndrome: Technical, hemodynamic, and clinical results of treatment with transjugular intrahepatic portosystemic shunt. Radiology 1995;197:805-811.
6. Rössle M: Transjugular intrahepatic portosystemic shunt (TIPS) - indication and outcome. Z Gastroenterol 1997;35:505-516.
7. Nolte W, Figulla HR, Ringe B, Wiltfang J, Münke H, Hartmann H, Ramadori G: TIPSS in the Budd-Chiari syndrome with portal vein thrombosis. Dtsch Med Wochenschr 1997;122:116-121.
8. Ringe B, Lang H, Oldhafer KJ, Gebel M, Flemming P, Georgii A, Borst HG, Pichlmayr R: Which is the best surgery for Budd-Chiari syndrome: Venous decompression or liver transplantation? A single-center experience with 50 patients. Hepatology 1995;21:1337-1344.
9. Ringe B, Canelo R, Lorf T, Klinge B, Schulze FP, Fischer U, Herrmann A, Ramadori G: Surgical therapy of benign liver tumors. Internist 1997; 38:944-953.
10. de Sousa JM, Portmann B, Williams R: Nodular regenerative hyperplasia of the liver and the Budd-Chiari syndrome. Case report, review of the literature and reappraisal of pathogenesis. J Hepatol 1991;12:28-35.
11. Simson IW: Memebranous obstruction of the inferior vena cava and hepatocellular carcinoma in South Africa. Gastroenterology 1982;68:171-178.
12. Nakamura T, Nakamura S, Aikawa T, et al: Obstruction of the inferior vena cava in the hepatic portion and the hepatic veins. Report of 8 cases and review of the Japanese literature. Angiology 1968;19:479-498.
13. Okuda H, Yamagata H, Obata, et al: Epidemiological and clinical features of Budd-Chiari syndrome in Japan. J Hepatol 1995;22:1-9.
14. Kew MC, McKnight A, Hodkinson J, Bukofzer S, Esser JD: The role of membranous obstruction of the inferior vena cava in the etiology of hepatocellular carcinoma in Southern African blacks. Hepatology 1989;9:121-125.
15. Rector WG Jr, Xu Y, Goldstein L, Peters RL, Reynolds TB: Membranous obstruction of the inferior vena cava in the United States. Medicine 1985;64:134-143.
16. Nzeako UC, Goodman ZD, Ishak KG: Hepatocellular carcinoma and nodular regenerative hyperplasia: Possible pathogenetic relationship. Am J Gastroenterol 1996;91:879-884.
17. Bass NM, Ockner RK: Drug-induced liver disease; in Zakim D, Boyer TD (eds): Hepatology -A Textbook of Liver Disease, 3rd ed. Philadelphia, Saunders, 1996, pp 962-1017.
18. Valla D, Le MG, Poynard T, Zucman N, Rueff B, Benhamou JP: Risk of hepatic vein thrombosis in relation to recent use of oral contraceptives. A case-control study. Gastroenterology 1986; 90:807-811.
19. Wanless IR, Mawdsley C, Adams R: On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology 1985;5:1194-1200.
20. Ross D, Pina J, Mirza M, Galvan A, Ponce L: Regression of focal nodular hyperplasia after discontinuation of oral contraceptives. Ann Intern Med 1976;82:203-204.
21. Hadjis NS, Blumgart LH: Liver hyperplasia and atrophy: Clinical relevance; in Blumgart LH (ed): Surgery of the Liver and Biliary Tract. Edinburgh, Churchill Livingstone, 1988, pp 61-71.
22. Schweizer W, Duda P, Tanner S, Balsiger D, Höflin F, Blumgart LH, Zimmermann A: Experimental atrophy/hypertrophy complex (AHC) of the liver: Portal vein, but not bile duct obstruction, is the main driving force for the developpent of AHC in the rat. J Hepatol 1995;23:71-78.
23. Grün R, Grün M, Rolfs A, Kaffarnik H: Hyperöstrogenämie nach verschiedenen Shuntoperationen: Zur Rolle der Östrogene bei der Entstehung der fokal nodulären Hyperplasie der Leber. Z Gastroenterol 1989;27:378-382.
24. Grün M, Liehr H, Heine WD, Rasenack U: Inhibition of nodular hepatic hyperplasia after portocaval anastomosis in rats by pancreatic blood; in Remmer H, Bolt HM, Bannasch P, Popper H (eds): Primary Liver Tumors. Lancaster, MTP Press, 1977, pp 401-408.
25. Lee S, Chandler JG, Broelsch CE, et al: The effect of hepatic interposition on ovary-pituitary interaction. J Microsurg 1980;1:440-446.
26. Flemming P, Grothe W, Vogelbruch M, Maschek H, Oldhafer K, Lang H, Georgii A: Die fokale noduläre Hyperplasie der Leber: Zur Rolle der portalen Minderperfusion. Verh Dtsch Ges Pathol 1995;79:658.